Screener / SEC EDGAR /CIK 0002046386 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Instruments

Medline Inc. MDLN

Compare with peers Embed
Why it changed

The biggest changes in the 10-K filed Feb 25, 2026, in management's words

10-K, Item 7

This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Revenue

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

+11.5%

“Net sales for the U.S. business for the year ended December 31, 2025 increased $2,732 million, or 11.5%, to $26,479 million, compared to $23,747 million for the respective period in 2024, primarily driven by volume growth in Prime Vendor net sales, which for the year ended December 31, 2025 increased $2,000 million, or 12.5%, to $18,033 million, compared to $16,033 million for the respective period in 2024.”

Read it in the 10-K

“The increase in Prime Vendor net sales was comprised primarily of $1,229 million related to new Prime Vendor relationships and $998 million related to existing Prime Vendor relationships, partially offset by a decrease of $227 million related to lost Prime Vendor relationships.”

Read it in the 10-K

Gross margin

Change, FY to Dec 31, 2025 vs Dec 31, 2024

27.3% to 26.4% (-0.9 pts)

“Cost of goods sold for the year ended December 31, 2025 increased $2,383 million, or 12.9%, to $20,914 million, compared to $18,531 million for the respective period in 2024, primarily driven by the growth in net sales, including the impact of acquisitions as noted above.”

Read it in the 10-K

“Gross profit as a percentage of sales decreased from 27.3% for the year ended December 31, 2024 to 26.4% for the year ended December 31, 2025, primarily driven by 115 basis points from higher import costs due to tariffs.”

Read it in the 10-K

Operating margin

Change, FY to Dec 31, 2025 vs Dec 31, 2024

8.4% to 7.8% (-0.6 pts)

“Other Operating ExpensesOther operating expenses for the year ended December 31, 2025 increased $41 million to $78 million, compared to $37 million for the respective period in 2024, primarily due to higher expenses associated with our IPO.”

Read it in the 10-K

Cash from operations

Change, FY to Dec 31, 2025 vs Dec 31, 2024

-1.4%

The MD&A has no sentence that names a cause for this change.

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K

Sources

The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.

Also

Financials: the numbers year by year.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDLN/export.csv") into a cell.

Next:Accounting checks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.